Failure of ALS drug puts a spotlight on controversial FDA approvals
Washington Post
A large clinical trial found that Amylyx Pharmaceuticals’ drug to treat ALS doesn’t work, raising questions about the FDA’s process for approving it.
https://www.washingtonpost.com/business/2024/03/16/als-drug-relyvrio-fda/